医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Exactech Earns Research Award at International Computer-Assisted Surgery Conference for ExactechGPS® Knee Application

2018年06月21日 AM05:47
このエントリーをはてなブックマークに追加


 

GAINESVILLE, Fla.

Exactech, a leading developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, earned the Second Place Best Clinical Podium Presentation Award for one of five new research studies presented on the company’s latest computer guidance technology for knee surgery at the International Society for Computer Assisted Orthopaedic Surgery (CAOS) annual meeting in Beijing, China earlier this month.

The award-winning research demonstrated the potential for ExactechGPS to accurately manage soft tissue balance, bone cuts and overall alignment of the knee in joint replacement surgery.

According to Orthopaedic Surgeon David Liu, MD, of The Gold Coast Centre for Bone & Joint Surgery in Queensland, Australia, “It was an honour to present several studies based on ExactechGPS and to receive this award, along with my co-authors Yifei Dai and Guillaume Bras of Exactech. This scientific meeting is unique in its focus on the role of navigation in orthopaedic surgery. I am confident that this technology plays a major role in the outcomes of joint arthroplasty.”

The five ExactechGPS studies presented at CAOS 2018 add to the more than 20 presented so far this year, including one that was recognized as the 2018 Orthopaedic Research Society’s Best Implant Poster Award. For more information on Exactech’s solutions for knee replacement and its ExactechGPS technology, visit www.exac.com.

About Exactech

Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech can be found at http://www.exac.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180620006300/en/

CONTACT

Exactech
Media Contact:
Priscilla Bennett, 352-377-1140
VP
of Marketing and Corporate Communications, Exactech
media@exac.com

同じカテゴリーの記事 

  • ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial
  • PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA
  • AriBio 获得欧洲药品管理局对AR1001治疗阿尔茨海默病3期临床试验(POLARIS-AD)的授权
  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)
  • ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続